Atomic structure of essential circadian clock protein complex determined

Discovery of possible basis for treating circadian clock disorders and associated metabolic problems

2014-05-30

(Press-News.org) Structural biologists have made important progress towards better understanding the functioning of the circadian clock. The circadian or inner clock coordinates the sleep-wake rhythm and many other body processes that regulate, for example, metabolism, blood pressure, and the immune system. A research team led by Professor Eva Wolf, recently appointed Professor of Structural Biology at the Institute of General Botany of Johannes Gutenberg University Mainz (JGU) and Adjunct Director at the Institute of Molecular Biology (IMB), has for the first time identified the molecular structure of a protein complex that plays an important role in regulating the circadian rhythm. At the same time, they also made a surprising discovery: The protein complex contains a zinc ion, which apparently stabilizes it. These results could form the basis for new strategies for treating illnesses that are the result of circadian clock dysfunction.

"Our circadian clock controls many important physiological functions," explained Professor Eva Wolf. If the natural rhythm is disrupted, as for example in the case of people on shift work, the likelihood of developing metabolic disorders, diabetes, or cancer is significantly increased. The fundamental research conducted in the Wolf group is focused on obtaining insight into the molecular mechanisms of the circadian clock. Among the currently investigated topics are the cryptochromes, a class of proteins associated with the circadian clock in mammals. In addition to regulating circadian rhythm, these also control glucose homeostasis and blood sugar levels. Together with another clock protein called period they form a complex, the structure of which has just been determined by Wolf's team.

By x-ray analysis of the cryptochrome-period complex structure, the researchers were able to observe atomic details of the interaction between the cryptochrome and period proteins and also discovered that the zinc ion mediates this interaction. "The metal ion stabilizes the complex and also appears to influence an adjacent disulfide bond," clarified Wolf. Cell biological studies conducted in the collaborating group of Prof. Dr. Achim Kramer at the Charite Berlin showed that this also is the case in human cells.

The researchers had not expected to detect a disulfide bond in the presence of the redox state that prevails in the cytoplasm and the cell nucleus. Its existence is probably regulated by the zinc ion and the disulfide bond itself is perhaps a sensor that indicates the metabolic status of the cell.

"We assume that the formation of this cryptochrome-period protein complex provides a mechanism by which the circadian clock interacts with the metabolism, while the zinc ion and the disulfide bond play an important role in regulating the stability of the complex," summarized Wolf. The now Mainz-based biologist hopes that further findings about the basic functioning of the cryptochrome-period complex and her aim of determining the interaction patterns of further clock proteins may help in the development of future medical treatments.

INFORMATION: About the Institute for Molecular Biology gGmbH The Institute of Molecular Biology gGmbH (IMB) is a center of excellence in the life sciences that was established in 2011. Research at IMB concentrates on three cutting-edge areas: epigenetics, developmental biology, and DNA repair. The institute is a prime example of a successful collaboration between public authorities and a private foundation. The Boehringer Ingelheim Foundation has dedicated EUR 100 million for a period of 10 years to cover the operating costs for research at IMB, while the state of Rhineland-Palatinate provided approximately EUR 50 million for the construction of a state-of-the-art building. For more information about IMB, please visit http://www.imb.de

About the Boehringer Ingelheim Foundation The Boehringer Ingelheim Foundation is an independent, non-profit organization committed to the promotion of the medical, biological, chemical, and pharmaceutical sciences. It was established in 1977 by Hubertus Liebrecht (1931-1991), a member of the shareholder family of the company Boehringer Ingelheim. Through its PLUS 3 Perspectives Program and Exploration Grants, the foundation supports independent group leaders; it also endows the internationally renowned Heinrich Wieland Prize as well as awards for up-and-coming scientists. The foundation has granted EUR 100 million over a period of ten years to finance the scientific activities of the Institute of Molecular Biology (IMB). For more information about the foundation and its programs, please visit http://www.boehringer-ingelheim-stiftung.de

ELSE PRESS RELEASES FROM THIS DATE:

Coaxing iPS cells to become more specialized prior to transplantation cuts rejection risk

2014-05-30

STANFORD, Calif. — For many scientists, the clinical promise of stem cells has been dampened by very real concerns that the immune system will reject the transplanted cells before they could render any long-term benefit. Previous research in mice has suggested that even stem cells produced from the subject's own tissue, called iPS cells, can trigger an immune attack. Now researchers at the Stanford University School of Medicine have found that coaxing iPS cells in the laboratory to become more-specialized progeny cells (a cellular process called differentiation) before ...

Standard approaches to menopause symptoms discount non-Western experiences

2014-05-30

Dr Mwenza T. Blell of the University of Bristol interviewed 257 British Pakistani women aged 39-61 living in West Yorkshire and found that the standard checklist approach to studying menopause symptoms, which ignores women's understanding of their own experience, leaves researchers and clinicians with gaps in their knowledge of the 'true' symptoms of menopause. Many previous studies into the menopause have relied on standardised checklists, such as the Blatt-Kupperman index and the Menopause Symptom Checklist, that were derived from the clinical experiences of women living ...

New software tool identifies genetic mutations that influence disease risk

2014-05-30

HOUSTON-Researchers at The University of Texas MD Anderson Cancer Center and other institutions have applied a newly developed software tool to identify genetic mutations that contribute to a person's increased risk for developing common, complex diseases, such as cancer. The research is published in the May 2014 edition of the journal Nature Biotechnology. The technology, known as pVAAST (pedigree Variant Annotation, Analysis and Search Tool), combines two different statistical methods used for identifying disease-causing gene mutations. This combination approach outperforms ...

Study links urbanization and future heat-related mortality

2014-05-30

TEMPE, Ariz. – Phoenix stands at a parched crossroads. Global scale climate change is forecast to bring hotter summers and more extreme heat to the Valley, but regional urbanization also will impact temperatures experienced by residents. So how should Phoenix grow knowing that such growth could cause temperatures to increase in the future and bring added health risks? Should the city deploy mitigating technologies to help fight summer's heat? Would adopting a low-growth strategy reduce the adverse health consequences of hot weather? New Arizona State University research ...

DNA-binding fluorescent dyes detect real-time cell toxicity during drug screening

2014-05-30

New Rochelle, NY, May 30, 2014—High throughput screening of compounds in live cells is a powerful approach for discovering new drugs, but the potential for cell toxicity must be considered. A novel technique that uses DNA-binding fluorescent dyes to evaluate the cytotoxicity of an experimental compound in real-time during screening, saving time and resources, is described in ASSAY and Drug Development Technologies, a peer-reviewed journal from Mary Ann Liebert, Inc., publishers. The article is available on the ASSAY and Drug Development Technologies website. Lucius Chiaraviglio ...

Study explains how green tea could reduce pancreatic cancer risk

2014-05-30

LOS ANGELES – (May 30, 2014) – Green tea and its extracts have been widely touted as potential treatments for cancer, as well as several other diseases. But scientists have struggled to explain how the green tea and its extracts may work to reduce the risk of cancer or to slow the growth of cancer cells. A study recently published online by the journal, Metabolomics, offers an explanation that researchers say could open a new area of cancer-fighting research. The study reports that EGCG, the active biologic constituent in green tea, changed the metabolism of pancreatic ...

Research shows overall survival benefit for patients with Stage III soft tissue sarcomas

2014-05-30

CHICAGO, IL (May 30, 2014)—Fox Chase Cancer Center researchers have carried out the first retrospective analysis of adjuvant chemotherapy's impact on overall survival in patients with stage III soft tissue sarcomas (STS), adjusted for socioeconomic status and other variables. The findings show that regardless of socioeconomic status and comorbidities, adjuvant chemotherapy improved survival by approximately 23 percent in stage III STS. Study leader Sujana Movva, MD, Medical Oncologist at Fox Chase, will present the findings the 50th Annual Meeting of the American Society ...

More patients with ovarian cancer are receiving chemotherapy before surgery

2014-05-30

CHICAGO, IL (May 30, 2014)—The use of chemotherapy before surgery to remove ovarian cancer has increased dramatically in recent decades, particularly among certain patients, according to a new analysis from Fox Chase Cancer Center that will be presented at the 50th Annual Meeting of the American Society of Clinical Oncology. Looking back at medical records from more than 58,000 women, Fox Chase's Angela Jain, MD, Medical Oncologist and co-investigator Elizabeth Handorf, PhD, member of the Biostatistics and Bioinformatics Facility, found that only 8.94% received chemotherapy ...

Compounds in saliva and common body proteins may fend off DNA-damaging chemicals

2014-05-30

A compound in saliva, along with common proteins in blood and muscle, may protect human cells from powerful toxins in tea, coffee and liquid smoke flavoring, according to results of a new study led by investigators at the Johns Hopkins Kimmel Cancer Center. The findings, reported online May 19 in Food and Chemical Toxicology, suggest that people naturally launch multiple defenses against plant chemicals called pyrogallol-like polyphenols or PLPs found in teas, coffees and liquid smoke flavoring. The presence of these defenses could help explain why PLPs are not crippling ...

New satellite animation shows the end of Hurricane Amanda

2014-05-30

VIDEO: This animation of visible and infrared imagery from NOAA's GOES-West satellite shows the weakening of Hurricane Amanda from May 28 to its dissipation on May 30. Click here for more information. A new animation of visible and infrared imagery from NOAA's GOES-West satellite shows the weakening and dissipation of the Eastern Pacific Ocean's Hurricane Amanda. The animation that runs from from May 28 to May 30 was created at NASA/NOAA's GOES Project at NASA's Goddard Space ...

LAST 30 PRESS RELEASES:

AI finds undiagnosed liver disease in early stages

The American Society of Tropical Medicine and Hygiene and the Bill & Melinda Gates Foundation announce new research fellowship in malaria genomics in honor of professor Dominic Kwiatkowski